Evidence map›Paper›PMID 30747479›Full record

ArticleVeterinary medicine and science2019

Identification and genomic characterization of the first isolate of bluetongue virus serotype 5 detected in Australia.

John R White, David T Williams, Jianning Wang, Honglei Chen, Lorna F Melville, Steven S Davis, Richard P Weir, Andrea Certoma, Antonio Di Rubbo, Gemma Harvey and 2 more

Open access · goldAbstract read
In one paragraph

Article in Veterinary medicine and science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Prospects of Next-Generation Vaccines for Bluetongue.Frontiers in veterinary science · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

John R WhiteCSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.ORCID 0000-0003-2112-7185
David T WilliamsCSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Jianning WangCSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Honglei ChenCSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Lorna F MelvilleDepartment of Primary Industry and Resources, Berrimah Veterinary Laboratories, Northern Territory Government, Berrimah, Northern Territory, Australia.
Steven S DavisDepartment of Primary Industry and Resources, Berrimah Veterinary Laboratories, Northern Territory Government, Berrimah, Northern Territory, Australia.
Richard P WeirDepartment of Primary Industry and Resources, Berrimah Veterinary Laboratories, Northern Territory Government, Berrimah, Northern Territory, Australia.
Andrea CertomaCSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Antonio Di RubboCSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Gemma HarveyCSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Ross A LuntCSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Debbie EaglesCSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Commonwealth Scientific and Industrial Research Organisation · AUGovernment of the Northern Territory · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bluetongue virus (BTV), transmitted by midges (Culicoides sp), is distributed worldwide and causes disease in ruminants. In particular, BT can be a debilitating disease in sheep causing serious trade and socio-economic consequences at both local and global levels. Across Australia, a sentinel cattle herd surveillance program monitors the BTV activity. Prior to 2014, BTV-1, -2, -3, -7, -9, -15, -16, -20, -21 and -23 had been isolated in Australia, but no bluetongue disease has occurred in a commercial Australian flock. We routinely use a combination of serology, virus isolation, RT-PCR and next generation and conventional nucleotide sequencing technologies to detect and phylogenetically characterize incursions of novel BTV strains into Australia. Screening of Northern Territory virus isolates in 2015 revealed BTV-5, a serotype new to Australia. We derived the complete genome of this isolate and determined its phylogenetic relationship with exotic BTV-5 isolates. Gene segments 2, 6, 7 and 10 exhibited a close relationship with the South African prototype isolate RSArrrr/5. This was the first Australian isolation of a Western topotype of segment 10. Serological surveillance data highlighted the antigenic cross-reactivity between BTV-5 and BTV-9. Phylogenetic investigation of segments 2 and 6 of these serotypes confirmed their unconventional relationships within the BTV serogroup. Our results further highlighted a need for a revision of the current serologically based system for BTV strain differentiation and importantly, implied a potential for genome segments of pathogenic Western BTV strains to rapidly enter Southeast Asia. This emphasized a need for continued high-level surveillance of vectors and viruses at strategic locations in the north of Australia The expansion of routine characterization and classification of BTV to a whole genome approach is recommended, to better monitor the presence and level of establishment of novel Western topotype segments within the Australian episystem.

Indexed as

Genome, ViralAnimalsBluetongueBluetongue virusCattleCattle DiseasesEpidemiological MonitoringNorthern TerritoryPhylogenySerogroupWestern Australiabluetongue virusgenotypephenotypeserologytopotypewhole genome

Identifiers

PMID30747479
PMCPMC6556758
OpenAlexW2914571810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.